Insider Trading activities of La Jolla Pharmaceutical Co insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of La Jolla Pharmaceutical Co since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of La Jolla Pharmaceutical Co since year 2005. Table 2 shows the detailed insider transactions of La Jolla Pharmaceutical Co since 2005. The reporting company's ticker symbol is LJPC. The reporting company's CIK number is 920465.
The total value of stock buying since 2005 is $173,657,513.
The total value of stock sales since 2005 is $5,172,528.
The total value of stock option exercises since 2005 is $594.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for La Jolla Pharmaceutical Co (LJPC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-03 255,354 $8,673,423 0 $0 0 $0
2016-09 139,035 $2,755,403 0 $0 0 $0
2016-03 20,000 $396,920 0 $0 0 $0
2015-09 80,485 $3,053,461 0 $0 0 $0
2015-08 170,000 $4,598,300 0 $0 0 $0
2015-06 330,000 $7,485,036 0 $0 0 $0
2015-05 194,890 $3,554,871 0 $0 0 $0
2014-12 236,925 $3,037,990 0 $0 0 $0
2014-09 176,555 $1,614,568 0 $0 0 $0
2014-07 19,381 $203,130 0 $0 0 $0
2014-05 12,000 $88,440 0 $0 0 $0
2014-04 8,000 $76,240 0 $0 0 $0
2014-02 3,000 $21,750 0 $0 0 $0
2013-03 100,000 $9,300 0 $0 0 $0
2012-08 500,000 $47,940 0 $0 0 $0
2012-07 499,980 $41,956 0 $0 0 $0
2011-05 0 $0 99,166 $1,586 99,166 $594
2011-04 0 $0 4,476 $3,163 0 $0
2010-03 20 $18,723 0 $0 0 $0
2009-08 0 $0 4,464,676 $828,373 0 $0
2009-07 0 $0 112,880 $20,882 0 $0
2009-06 0 $0 5,713,877 $1,204,022 0 $0
2009-02 0 $0 31,143,600 $3,045,250 0 $0
2009-01 100,000 $140,143 0 $0 0 $0
2008-05 24,519,395 $46,341,653 0 $0 0 $0
2008-03 551,100 $1,168,332 0 $0 0 $0
2007-12 107,508 $406,204 400 $1,560 0 $0
2007-09 85,000 $378,250 0 $0 0 $0
2007-08 13,000 $55,509 0 $0 0 $0
2007-06 400,000 $1,848,000 0 $0 0 $0
2007-04 5,333,332 $31,999,992 0 $0 0 $0
2007-02 1,900 $5,899 0 $0 0 $0
2007-01 0 $0 11,963 $36,657 0 $0
2006-12 94,300 $281,356 10,365 $31,035 0 $0
2006-10 50,000 $168,000 0 $0 0 $0
2006-05 47,272 $186,724 0 $0 0 $0
2005-12 73,333,334 $55,000,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of La Jolla Pharmaceutical Co insiders (LJPC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-03-23 Tang Capital Management Llc (10% Owner) Buy 149,254 33.50 5,000,009
2017-03-03 Chawla Lakhmir S (Chief Medical Officer) Buy 1,000 34.48 34,480
2017-03-03 Tidmarsh George F (President, CEO & Secretary) Buy 1,000 34.15 34,150
2017-03-03 Mulroy Dennis (Chief Financial Officer) Buy 500 33.95 16,975
2017-03-02 Carver Jennifer (Chief Operating Officer) Buy 1,000 34.46 34,457
2017-03-02 Chawla Lakhmir S (Chief Medical Officer) Buy 600 35.33 21,198
2017-03-02 Tidmarsh George F (President, CEO & Secretary) Buy 2,000 34.18 68,354
2017-03-02 Tang Capital Management Llc (10% Owner) Buy 100,000 34.64 3,463,800
2016-09-13 Tang Capital Management Llc (10% Owner) Buy 16,448 20.28 333,516
2016-09-12 Tang Capital Management Llc (10% Owner) Buy 22,587 19.92 449,887
2016-09-09 Tang Capital Management Llc (10% Owner) Buy 100,000 19.72 1,972,000
2016-03-04 Tang Capital Management Llc (10% Owner) Buy 20,000 19.85 396,920
2015-09-28 Chawla Lakhmir S (Chief Medical Officer) Buy 485 27.75 13,461
2015-09-10 Tang Capital Management Llc (10% Owner) Buy 80,000 38.00 3,040,000
2015-08-21 Tang Capital Management Llc (10% Owner) Buy 50,000 27.69 1,384,500
2015-08-20 Tang Capital Management Llc (10% Owner) Buy 50,000 26.84 1,342,000
2015-08-19 Tang Capital Management Llc (10% Owner) Buy 70,000 26.74 1,871,800
2015-06-26 Tang Capital Management Llc (10% Owner) Buy 110,000 23.58 2,593,470
2015-06-24 Tang Capital Management Llc (10% Owner) Buy 88,314 22.94 2,026,188
2015-06-23 Tang Capital Management Llc (10% Owner) Buy 53,836 22.27 1,198,766
2015-06-22 Tang Capital Management Llc (10% Owner) Buy 77,850 21.41 1,666,612
2015-05-14 Zarrabian Saiid Buy 307 19.50 5,986
2015-05-13 Tang Capital Management Llc (10% Owner) Buy 47,483 18.63 884,513
2015-05-12 Tidmarsh George F (President, CEO & Secretary) Buy 4,000 18.37 73,480
2015-05-12 Tang Capital Management Llc (10% Owner) Buy 44,400 18.25 810,344
2015-05-11 Tang Capital Management Llc (10% Owner) Buy 98,700 18.04 1,780,548
2014-12-16 Tang Capital Management Llc (10% Owner) Buy 582 13.95 8,116
2014-12-15 Tang Capital Management Llc (10% Owner) Buy 32,343 13.93 450,570
2014-12-12 Tang Capital Management Llc (10% Owner) Buy 77,304 13.71 1,059,837
2014-12-11 Tidmarsh George F (President, CEO & Secretary) Buy 4,000 11.38 45,520
2014-12-11 Tang Capital Management Llc (10% Owner) Buy 122,696 12.01 1,473,947
2014-09-26 Tidmarsh George F (President, CEO & Secretary) Buy 2,000 9.35 18,700
2014-09-26 Tang Capital Management Llc (10% Owner) Buy 44,055 9.21 405,878
2014-09-25 Tang Capital Management Llc (10% Owner) Buy 30,500 9.17 279,685
2014-09-24 Tang Capital Management Llc (10% Owner) Buy 95,000 9.10 864,405
2014-09-18 Tidmarsh George F (President, CEO & Secretary) Buy 5,000 9.18 45,900
2014-07-31 Zarrabian Saiid Buy 381 9.53 3,630
2014-07-23 Tidmarsh George F (President, CEO & Secretary) Buy 19,000 10.50 199,500
2014-05-21 Tidmarsh George F (President, CEO & Secretary) Buy 12,000 7.37 88,440
2014-04-14 Tidmarsh George F (President, CEO & Secretary) Buy 4,000 9.30 37,200
2014-04-11 Tidmarsh George F (President, CEO & Secretary) Buy 4,000 9.76 39,040
2014-02-07 Tidmarsh George F (President, CEO & Secretary) Buy 3,000 7.25 21,750
2013-03-19 Reinisch Richard Buy 100,000 .09 9,300
2012-08-02 Reinisch Richard Buy 220,695 .10 21,407
2012-08-01 Reinisch Richard Buy 279,305 .10 26,533
2012-07-25 Reinisch Richard Buy 121,200 .09 10,908
2012-07-24 Reinisch Richard Buy 144,780 .09 13,030
2012-07-23 Reinisch Richard Buy 234,000 .08 18,018
2011-05-17 Gillespie Deirdre (President & CEO) Sale 99,166 .02 1,586
2011-05-09 Gillespie Deirdre (President & CEO) Option Ex 99,166 .01 594
2011-04-20 Sloan Gail A (Chief Financial Officer) Sale 100 1.00 100
2011-04-19 Gillespie Deirdre (President & CEO) Sale 4,376 .70 3,063
2010-03-12 Reinisch Richard Buy 20 936.20 18,723
2009-08-06 Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) Sale 437,593 .18 80,079
2009-08-06 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Sale 368,872 .18 67,503
2009-08-06 Sloan Gail A (VP of Finance) Sale 1,810 .19 343
2009-08-06 Sutter Martin P (Director) Sale 824,465 .18 150,877
2009-08-05 Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) Sale 623,026 .19 116,505
2009-08-05 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Sale 792,942 .19 148,280
2009-08-05 Sutter Martin P (Director) Sale 1,415,968 .19 264,786
2009-07-29 Sutter Martin P (Director) Sale 112,880 .18 20,882
2009-06-25 Sloan Gail A (VP of Finance) Sale 2,230 .18 401
2009-06-19 Biomarin Pharmaceutical Inc (10% Owner) Sale 2,546,958 .21 524,673
2009-06-18 Sloan Gail A (VP of Finance) Sale 4,914 .20 982
2009-06-18 Biomarin Pharmaceutical Inc (10% Owner) Sale 2,198,825 .21 461,753
2009-06-17 Biomarin Pharmaceutical Inc (10% Owner) Sale 960,950 .23 216,213
2009-02-26 Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) Sale 3,328,747 .05 169,766
2009-02-26 Topper James N (Director) Sale 2,756,711 .06 154,375
2009-02-26 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Sale 4,236,586 .05 216,065
2009-02-26 Fildes Robert Phd (Director) Sale 16,612 .05 863
2009-02-26 Smith Craig R (Director) Sale 27,200 .06 1,496
2009-02-25 Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) Sale 1,717,737 .06 108,217
2009-02-25 Topper James N (Director) Sale 1,454,000 .06 91,602
2009-02-25 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Sale 2,186,211 .06 137,731
2009-02-24 Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) Sale 1,700,312 .07 124,122
2009-02-24 Fhm V, Lp (10% Owner) Sale 1,662,000 .07 119,663
2009-02-24 Topper James N (Director) Sale 1,662,000 .07 119,663
2009-02-24 Elchico Josefina T (VP Quality Operations) Sale 25,759 .10 2,575
2009-02-24 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Sale 2,164,033 .07 157,974
2009-02-12 Gonzalez Alejandro (10% Owner) Sale 8,205,692 .20 1,641,138
2009-01-23 Sutter Martin P (Director) Buy 31,091 1.48 46,014
2009-01-22 Sutter Martin P (Director) Buy 68,909 1.37 94,129
2008-05-12 Essex Woodlands Health Ventures Fund Vii Lp (10% Owner) Buy 7,807,415 1.89 14,756,014
2008-05-12 Frazier Healthcare V, Lp (10% Owner) Buy 1,039,378 1.89 1,964,424
2008-05-12 Gonzalez Alejandro (10% Owner) Buy 1,619,256 1.89 3,060,393
2008-05-12 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Buy 2,081,977 1.89 3,934,936
2008-05-12 Sutter Martin P (Director) Buy 9,889,392 1.89 18,690,950
2008-03-10 Gonzalez Alejandro (10% Owner) Buy 551,100 2.12 1,168,332
2007-12-20 Elchico Josefina T (VP Quality Operations) Sale 400 3.90 1,560
2007-12-18 Gonzalez Alejandro (10% Owner) Buy 50,000 3.93 196,300
2007-12-14 Gonzalez Alejandro (10% Owner) Buy 57,508 3.65 209,904
2007-09-12 Gonzalez Alejandro (10% Owner) Buy 75,000 4.45 333,750
2007-09-11 Gonzalez Alejandro (10% Owner) Buy 10,000 4.45 44,500
2007-08-31 Gonzalez Alejandro (10% Owner) Buy 13,000 4.27 55,509
2007-06-14 Gonzalez Alejandro (10% Owner) Buy 400,000 4.62 1,848,000
2007-04-04 Naini Nader J (Director) Buy 833,333 6.00 4,999,998
2007-04-04 Topper James N (Director) Buy 833,333 6.00 4,999,998
2007-04-04 Gonzalez Alejandro (10% Owner) Buy 833,333 6.00 4,999,998
2007-04-04 Essex Woodlands Health Ventures Fund Vi L P (10% Owner) Buy 1,000,000 6.00 6,000,000
2007-04-04 Sutter Martin P (Director) Buy 1,000,000 6.00 6,000,000
2007-04-03 Fhm V, Lp (10% Owner) Buy 833,333 6.00 4,999,998
2007-02-05 Tansey Michael James Byron (Executive VP & CMO) Buy 1,900 3.10 5,899
2007-01-10 Koch Lisa I (Sr Dir Regulatory Affairs) Sale 652 3.02 1,970
2007-01-10 Jenn Paul (VP of Product Development) Sale 6,630 3.08 20,453
2007-01-09 Koch Lisa I (Sr Dir Regulatory Affairs) Sale 3,500 3.05 10,664
2007-01-03 Koch Lisa I (Sr Dir Regulatory Affairs) Sale 1,181 3.02 3,570
2006-12-29 Gonzalez Alejandro (10% Owner) Buy 25,000 3.12 78,000
2006-12-29 Jenn Paul (VP of Product Development) Sale 5,000 3.11 15,540
2006-12-27 Gonzalez Alejandro (10% Owner) Buy 8,600 3.12 26,832
2006-12-27 Linnik Matthew D (CSO & Exec VP of Research) Sale 365 3.03 1,105
2006-12-26 Gonzalez Alejandro (10% Owner) Buy 500 3.08 1,540
2006-12-22 Gonzalez Alejandro (10% Owner) Buy 40,200 2.92 117,384
2006-12-21 Gonzalez Alejandro (10% Owner) Buy 20,000 2.88 57,600
2006-12-21 Linnik Matthew D (CSO & Exec VP of Research) Sale 5,000 2.88 14,390
2006-10-17 Gonzalez Alejandro (10% Owner) Buy 15,000 3.56 53,400
2006-10-16 Gonzalez Alejandro (10% Owner) Buy 15,000 3.40 51,000
2006-10-13 Gonzalez Alejandro (10% Owner) Buy 20,000 3.18 63,600
2006-05-08 Gonzalez Alejandro (10% Owner) Buy 47,272 3.95 186,724
2005-12-14 Naini Nader J (Director) Buy 20,000,000 .75 15,000,000
2005-12-14 Topper James N (Director) Buy 20,000,000 .75 15,000,000
2005-12-14 Sutter Martin P (Director) Buy 33,333,334 .75 25,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of LJPC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of La Jolla Pharmaceutical Co (symbol LJPC, CIK number 920465) see the Securities and Exchange Commission (SEC) website.